Siena S, Bregni M, Formosa A, Brando B, Lappi D A, Bonadonna G, Gianni A M
Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy.
J Biol Regul Homeost Agents. 1989 Apr-Jun;3(2):84-8.
We isolated and treated in vitro with a novel CD5-specific saporin immunotoxin, referred to as OKT1-SAP, the cells infiltrating an irreversibly rejected renal allograft from a patient who rejected while on cyclosporine plus steroids and then failed to respond to multiple courses of high-dose steroids, intravenous OKT3 antibody, and local irradiation to the graft. We report here that under experimental conditions achievable in vivo the immunotoxin OKT1-SAP was capable of eliminating in vitro more than 95% of clonable T-lymphocytes infiltrating the rejected allograft of this patient despite their resistance to previous aggressive immunosuppression. To our knowledge, this is the first report of an immunotoxin-mediated suppression of the clonogenic growth of rejected renal allograft infiltrating T-lymphocytes.
我们从一名在接受环孢素加类固醇治疗期间发生排斥反应、随后对多疗程大剂量类固醇、静脉注射OKT3抗体及移植肾局部照射均无反应的患者体内,分离出不可逆排斥的肾移植浸润细胞,并在体外使用一种新型的CD5特异性皂草素免疫毒素(称为OKT1-SAP)进行处理。我们在此报告,在体内可实现的实验条件下,免疫毒素OKT1-SAP能够在体外消除该患者排斥移植肾中超过95%的可克隆T淋巴细胞,尽管这些细胞对先前的强化免疫抑制具有抗性。据我们所知,这是关于免疫毒素介导抑制排斥肾移植浸润T淋巴细胞克隆生长的首次报道。